Austin Kulasekararaj

Author PubWeight™ 11.34^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.	J Clin Oncol	2011	2.88
2	Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.	Blood	2010	2.13
3	Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.	Blood	2011	1.59
4	STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.	Blood	2013	1.59
5	Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.	N Engl J Med	2015	0.97
6	Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.	Blood	2013	0.95
7	Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies.	Haematologica	2013	0.90
8	Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.	Br J Haematol	2015	0.84
9	Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis.	Acta Haematol	2016	0.75
10	Aplastic anaemia.	Hematology	2013	0.75